Contact

Please use this form to send email to PR contact of this press release:
Kinder Holding Corp. Receives FINRA Approval for Name Change to Intiva BioPharma Inc.

TO:
Mark Lubchenco
Kinder Holding/Intiva BioPharma Inc.
303-431-4530

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image